Details for 2012700262

Up to date per 02.04.2026

Actions

Title / Product Name

IMMUNSUPPRESSIVE FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012700262

EP Publication Number

2661261

E-Number

1160186

Language

PCT Number

EP12050151

Publication Date

13.11.2013 A

31.07.2019 B1

Registration Date

31.07.2019

AT Publication Date

15.08.2019

Application Date

05.01.2012

Registration Number

Priorities

07.01.2011

11150431

IPC

A61K 9/20 20060101AFI20120725BHEP

Maximum Duration of Protection

05.01.2032

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

BOUILLOT, PhilippeNovartis Pharma AG Postfach CH-4002 BaselCH

REYNAUD, EmericNovartis Pharma AG CH-4002 BaselCH

Information about Fees